期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Antimicrobial Resistance and Infection Control LetPub Score 6.2
50 ratings
Rate
Reputation 7.0 Influence 5.0 Speed 9.2 | ||||||||||||||||||||||||||||
期刊簡稱 | ANTIMICROB RESIST IN | ||||||||||||||||||||||||||||
ISSN | 2047-2994 | ||||||||||||||||||||||||||||
h-index | 24 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 4.20%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | https://www.springer.com/journal/13756 | ||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ARIC | ||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||||||||||
主題領域 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||||||
創刊年 | 2012 | ||||||||||||||||||||||||||||
每年文章數 | 137每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 99.34% | ||||||||||||||||||||||||||||
OA Related Info | APC: Yes( GBP2190; USD3090; EUR2590; ) APC waiver:Check Notes Other charges: No Keywords: communicable disease control Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2047-2994%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 13 Weeks | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Antimicrobial Resistance and Infection Control] 的評論 | 撰寫評論 |
作者: wenjing 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-09-25 20:12:15 評論於 The editor was very nice. He didn’t reject my manuscript because of the low-level errors that the format did not fully meet the requirements of the journal at the submission stage, but just notified a revision. I shall have to doublecheck in future submissions to reduce low-level errors that may affect the first impression. The review speed of this journal is much faster than those of BMC that I previously submitted to. A major revision was recommended 2 months later. A minor revision was required 20 days after the revised submission. It was accepted 15 days later. (5) 讚! | wenjing |
作者: 是迎蕊吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-25 20:12:13 評論於 Review speed: 2.0 Experience sharing: The editor is very nice. For minor errors that do not completely meet the magazine's requirements when submitting the manuscript, they did not immediately reject it, but notified for revision. In the future, it is still necessary to check repeatedly when submitting a manuscript to reduce minor errors and impact the first impression. The review time of this journal is much faster than the original bmc series submission. They provided major revision comments in 2 months, returned minor revisions in about 20 days, and accepted the article in fifteen days(0) 讚! | 是迎蕊吖 |
作者: 彩色熊猫 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-08-06 17:17:12 評論於 The review efficiency was low; the review comments were very helpful to the improvement of the article. (2) 讚! | 彩色熊猫 |
作者: 五郎梓奥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-06 09:03:00 評論於 Review Speed: 3.0 Experience Sharing: The current review efficiency is low, and the review comments are very helpful for improving the article(0) 讚! | 五郎梓奥 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us